Mahkam Zanganeh is the Director, Chief Executive Officer, and President of SUMMIT THERAPEUTICS INC, a position that underscores his significant role in steering the company's strategic direction and operational execution. With a robust background in the biopharmaceutical industry, Zanganeh has been instrumental in advancing SUMMIT THERAPEUTICS INC's mission to develop innovative treatments for infectious diseases and cancer. His leadership is characterized by a keen focus on scientific excellence and patient-centric innovation, which has been pivotal in driving the company's growth and development. Prior to his appointment at SUMMIT THERAPEUTICS INC, Zanganeh held various leadership roles within the biopharmaceutical sector, where he honed his skills in corporate strategy, clinical development, and business development. His professional journey includes significant contributions to the advancement of novel therapies, and he has been recognized for his ability to navigate complex regulatory landscapes and foster collaborations that enhance therapeutic development. Under his stewardship, SUMMIT THERAPEUTICS INC has made notable strides in its clinical pipeline, particularly in the areas of antibiotic resistance and oncology, positioning the company as a leader in its field. As CEO and President, Zanganeh is responsible for overseeing the company's day-to-day operations and long-term strategic planning. His vision for SUMMIT THERAPEUTICS INC is to continue pushing the boundaries of medical science to deliver transformative treatments that address unmet medical needs. His commitment to excellence and innovation not only drives the company forward but also inspires his team to achieve their highest potential, ensuring that SUMMIT THERAPEUTICS INC remains at the forefront of the biopharmaceutical industry.